Skip to main content

Advertisement

SpringerLink
Log in

Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers

  • Letter to Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Maas M, Bedke J, Stenzl A, Todenhöfer T (2018) Can urinary biomarkers replace cystoscopy? World J Urol. https://doi.org/10.1007/s00345-018-2505-2 (Epub ahead of print)

    Article  PubMed  Google Scholar 

  2. Soria F, Droller MJ, Lotan Y et al (2018) An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J Urol 36:1981–1995. https://doi.org/10.1007/s00345-018-2380-x

    Article  PubMed  PubMed Central  Google Scholar 

  3. Faiena I, Rosser CJ, Chamie K et al (2018) Diagnostic biomarkers in non-muscle invasive bladder cancer. World J Urol. https://doi.org/10.1007/s00345-018-2567-1 (Epub ahead of print)

    Article  PubMed  Google Scholar 

  4. Lotan Y, Shariat SF, Schmitz-Drager BJ et al (2010) Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol 28:441–448. https://doi.org/10.1016/j.urolonc.2009.11.004

    Article  PubMed  Google Scholar 

  5. Witjes JA, Morote J, Cornel EB et al (2018) Performance of the Bladder EpiCheck™ Methylation Test for patients under surveillance for non–muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial. Eur Urol Onc 1:307–313. https://doi.org/10.1016/j.euo.2018.06.011

    Article  Google Scholar 

  6. Messer J, Shariat SF, Brien JC et al (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 108:701–705. https://doi.org/10.1111/j.1464-410X.2010.09899.x

    Article  PubMed  Google Scholar 

  7. Monteiro-Reis S, Leça L, Mafalda A et al (2014) Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation. Eur J Cancer 50:226–233. https://doi.org/10.1016/j.ejca.2013.08.025

    Article  CAS  PubMed  Google Scholar 

  8. Run-Qi G, Gen-Yan X, Kai-Wei Y et al (2018) Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: a prospective, single-center study. Urol Oncol 36(7):342.e15–342.e23. https://doi.org/10.1016/j.urolonc.2018.04.001

    Article  CAS  Google Scholar 

  9. Bensalah K, Montorsi F, Shariat SF (2007) Challenges of cancer biomarker profiling. Eur Urol 52:1601–1609. https://doi.org/10.1016/j.eururo.2007.09.036

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain

    Andrea Gallioli, Romain Boissier, Angelo Territo & Alberto Breda

  2. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

    Andrea Gallioli

  3. Department of Urology, Aix-Marseille University, APHM, La Conception Academic Hospital, Marseille, France

    Romain Boissier

Authors
  1. Andrea Gallioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Romain Boissier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angelo Territo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alberto Breda
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Gallioli: project development, data collection, and manuscript writing/editing. Boissier: data analysis and manuscript editing. Territo: data collection and management. Breda: project development and manuscript editing.

Corresponding author

Correspondence to Andrea Gallioli.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

After ethical committee approval, all patients enrolled in our study signed an informed consent.

Conflict of interest

All the authors declare that they have no potential conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gallioli, A., Boissier, R., Territo, A. et al. Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers. World J Urol 37, 1985–1986 (2019). https://doi.org/10.1007/s00345-018-2611-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-018-2611-1

Search

Navigation